Literature DB >> 25590443

Relationship between the climbing up and climbing down stairs domain scores on the FES-DMD, the score on the Vignos Scale, age and timed performance of functional activities in boys with Duchenne muscular dystrophy.

Lilian A Y Fernandes1, Fátima A Caromano1, Silvana M B Assis2, Michele E Hukuda1, Mariana C Voos1, Eduardo V Carvalho1.   

Abstract

BACKGROUND: Knowing the potential for and limitations of information generated using different evaluation instruments favors the development of more accurate functional diagnoses and therapeutic decision-making.
OBJECTIVE: To investigate the relationship between the number of compensatory movements when climbing up and going down stairs, age, functional classification and time taken to perform a tested activity (TA) of going up and down stairs in boys with Duchenne muscular dystrophy (DMD).
METHOD: A bank of movies featuring 30 boys with DMD performing functional activities was evaluated. Compensatory movements were assessed using the climbing up and going down stairs domain of the Functional Evaluation Scale for Duchenne Muscular Dystrophy (FES-DMD); age in years; functional classification using the Vignos Scale (VS), and TA using a timer. Statistical analyses were performed using the Spearman correlation test.
RESULTS: There is a moderate relationship between the climbing up stairs domain of the FES-DMD and age (r=0.53, p=0.004) and strong relationships with VS (r=0.72, p=0.001) and TA for this task (r=0.83, p<0.001). There were weak relationships between the going down stairs domain of the FES-DMD-going down stairs with age (r=0.40, p=0.032), VS (r=0.65, p=0.002) and TA for this task (r=0.40, p=0.034).
CONCLUSION: These findings indicate that the evaluation of compensatory movements used when climbing up stairs can provide more relevant information about the evolution of the disease, although the activity of going down stairs should be investigated, with the aim of enriching guidance and strengthening accident prevention. Data from the FES-DMD, age, VS and TA can be used in a complementary way to formulate functional diagnoses. Longitudinal studies and with broader age groups may supplement this information.

Entities:  

Mesh:

Year:  2014        PMID: 25590443      PMCID: PMC4311595          DOI: 10.1590/bjpt-rbf.2014.0063

Source DB:  PubMed          Journal:  Braz J Phys Ther        ISSN: 1413-3555            Impact factor:   3.377


  21 in total

1.  Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.

Authors:  Elaine Scott; Michelle Eagle; Anna Mayhew; Jenny Freeman; Marion Main; Jennie Sheehan; Adnan Manzur; Francesco Muntoni
Journal:  Physiother Res Int       Date:  2011-09-23

2.  Development of an evaluation scale for sitting and standing from the ground for children with Duchenne muscular dystrophy.

Authors:  Renata Escorcio; Fatima Aparecida Caromano; Michele Emy Hukuda; Lilian Aparecida Yoshimura Fernandes
Journal:  J Mot Behav       Date:  2011       Impact factor: 1.328

Review 3.  Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool.

Authors:  Elaine Scott; Susan J Mawson
Journal:  Dev Med Child Neurol       Date:  2006-06       Impact factor: 5.449

4.  Predicting the loss of ambulation in Duchenne muscular dystrophy.

Authors:  Edmar Zanoteli
Journal:  Arq Neuropsiquiatr       Date:  2014-01       Impact factor: 1.420

5.  Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne Muscular Dystrophy.

Authors:  Lilian A Y Fernandes; Fátima A Caromano; Michele E Hukuda; Renata Escorcio; Eduardo V Carvalho
Journal:  Rev Bras Fisioter       Date:  2010 Nov-Dec

6.  Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.

Authors:  Elaine C da Silva; Darlene L Machado; Maria B D Resende; Renata F Silva; Edmar Zanoteli; Umbertina C Reed
Journal:  Arq Neuropsiquiatr       Date:  2012-03       Impact factor: 1.420

7.  Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function.

Authors:  Susan Sienko Thomas; Cathleen E Buckon; Alina Nicorici; Anita Bagley; Craig M McDonald; Michael D Sussman
Journal:  J Child Neurol       Date:  2010-06-29       Impact factor: 1.987

8.  North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.

Authors:  Elena Mazzone; Diego Martinelli; Angela Berardinelli; Sonia Messina; Adele D'Amico; Gessica Vasco; Marion Main; Luca Doglio; Luisa Politano; Filippo Cavallaro; Silvia Frosini; Luca Bello; Adelina Carlesi; Anna Maria Bonetti; Elisabetta Zucchini; Roberto De Sanctis; Marianna Scutifero; Flaviana Bianco; Francesca Rossi; Maria Chiara Motta; Annalisa Sacco; Maria Alice Donati; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Marika Pane; Elisabetta Pasquini; Claudio Bruno; Giuseppe Vita; Chiara de Waure; Enrico Bertini; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2010-07-14       Impact factor: 4.296

9.  Evaluation scale development, reliability for sitting and standing from the chair for Duchenne muscular dystrophy.

Authors:  Michele Emy Hukuda; Renata Escorcio; Lilian Aparecida Yoshimura Fernandes; Eduardo Vital de Carvalho; Fátima Aparecida Caromano
Journal:  J Mot Behav       Date:  2013-03-14       Impact factor: 1.328

Review 10.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

View more
  1 in total

1.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.